Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-25-053090

Chief Scientific Officer sold 3,024 shares at $7.18 ($21,712)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Heier Jeffrey S. · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-05-23 Sale : show line 1 in the form 10b5-1 −3,024 $7.18 $21,712 262,974 D
Open-market sales · 3,024 sh · avg $7.18 · $21,712
Loading xslF345X05/tm2516174-2_4seq1.xml…